Dihydroartemisinin increased Beclin-1 and LC3-B expression levels, induced autophagy in glioma cells, inhibited cell viability, and enhanced the anti-tumor effect of temozolomide (Zhang et al., 2015). Here, BECN1 is linked to central nervous system cancer.